{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:16:54Z","timestamp":1794611814697,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Leonard Wolfson PhD Programme in Neurodegeneration"},{"DOI":"10.13039\/501100005302","name":"Onassis Foundation","doi-asserted-by":"crossref","award":["Scholarship ID: F ZQ 022-1\/2020-2021"],"award-info":[{"award-number":["Scholarship ID: F ZQ 022-1\/2020-2021"]}],"id":[{"id":"10.13039\/501100005302","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Health Research (NIHR) Biomedical Research Centre at UCL Hospitals NHS Foundation Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Prion diseases are fatal neurodegenerative conditions that affect humans and animals. Rapid and accurate sequencing of the prion gene\n                    <jats:italic>PRNP<\/jats:italic>\n                    is paramount to human prion disease diagnosis and for animal surveillance programmes. Current methods for\n                    <jats:italic>PRNP<\/jats:italic>\n                    genotyping involve sequencing of small fragments within the protein-coding region. The contribution of variants in the non-coding regions of\n                    <jats:italic>PRNP<\/jats:italic>\n                    including large structural changes is poorly understood. Here, we used long-range PCR and Nanopore sequencing to sequence the full length of\n                    <jats:italic>PRNP<\/jats:italic>\n                    , including its regulatory region, in 25 samples from blood and brain of individuals with inherited or sporadic prion diseases. Nanopore sequencing detected the same variants as identified by Sanger sequencing, including repeat expansions\/deletions. Nanopore identified additional single-nucleotide variants in the non-coding regions of\n                    <jats:italic>PRNP<\/jats:italic>\n                    , but no novel structural variants were discovered. Finally, we explored somatic mosaicism of\n                    <jats:italic>PRNP<\/jats:italic>\n                    \u2019s octapeptide repeat region, which is a hypothetical cause of sporadic prion disease. While we found changes consistent with somatic mutations, we demonstrate that they may have been generated by the PCR. Our study illustrates the accuracy of Nanopore sequencing for rapid and field prion disease diagnosis and highlights the need for single-molecule sequencing methods for the detection of somatic mutations.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-12130-7","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T08:06:10Z","timestamp":1652861170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prion protein gene mutation detection using long-read Nanopore sequencing"],"prefix":"10.1038","volume":"12","author":[{"given":"Fran\u00e7ois","family":"Kroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Darwent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Vire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"issue":"6","key":"12130_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41582-021-00488-7","volume":"17","author":"N Watson","year":"2021","unstructured":"Watson, N. et al. The importance of ongoing international surveillance for Creutzfeldt\u2013Jakob disease. Nat. Rev. Neurol. 17(6), 362\u2013379 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"12130_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev-genet-120213-092352","volume":"53","author":"S Mead","year":"2019","unstructured":"Mead, S., Lloyd, S. & Collinge, J. Genetic factors in mammalian prion diseases. Annu. Rev. Genet. 53, 117\u2013147 (2019).","journal-title":"Annu. Rev. Genet."},{"issue":"4","key":"12130_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0092-8674(85)90333-2","volume":"40","author":"B Oesch","year":"1985","unstructured":"Oesch, B. et al. A cellular gene encodes scrapie PrP 27\u201330 protein. Cell 40(4), 735\u2013746 (1985).","journal-title":"Cell"},{"issue":"D1","key":"12130_CR4","first-page":"D682","volume":"48","author":"AD Yates","year":"2020","unstructured":"Yates, A. D. et al. Ensembl 2020. Nucleic Acids Res. 48(D1), D682\u2013D688 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"12130_CR5","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1212\/WNL.0000000000007745","volume":"93","author":"EV Minikel","year":"2019","unstructured":"Minikel, E. V. et al. Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology 93(2), e125\u2013e134 (2019).","journal-title":"Neurology"},{"issue":"6333","key":"12130_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/352340a0","volume":"352","author":"MS Palmer","year":"1991","unstructured":"Palmer, M. S., Dryden, A. J., Hughes, J. T. & Collinge, J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt\u2013Jakob disease. Nature 352(6333), 340\u2013342 (1991).","journal-title":"Nature"},{"issue":"Pt 10","key":"12130_CR7","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1093\/brain\/awh249","volume":"127","author":"M Pocchiari","year":"2004","unstructured":"Pocchiari, M. et al. Predictors of survival in sporadic Creutzfeldt\u2013Jakob disease and other human transmissible spongiform encephalopathies. Brain 127(Pt 10), 2348\u20132359 (2004).","journal-title":"Brain"},{"issue":"9","key":"12130_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002242","volume":"7","author":"C Kim","year":"2011","unstructured":"Kim, C. et al. Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt\u2013Jakob disease are indicator of progression rate. PLoS Pathog. 7(9), e1002242 (2011).","journal-title":"PLoS Pathog."},{"issue":"1","key":"12130_CR9","doi-asserted-by":"publisher","first-page":"13211","DOI":"10.1038\/s41598-018-31394-6","volume":"8","author":"Z Zheng","year":"2018","unstructured":"Zheng, Z. et al. Structural basis for the complete resistance of the human prion protein mutant G127V to prion disease. Sci. Rep. 8(1), 13211 (2018).","journal-title":"Sci. Rep."},{"issue":"7557","key":"12130_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nature14510","volume":"522","author":"EA Asante","year":"2015","unstructured":"Asante, E. A. et al. A naturally occurring variant of the human prion protein completely prevents prion disease. Nature 522(7557), 478\u2013481 (2015).","journal-title":"Nature"},{"issue":"6","key":"12130_CR11","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1074\/jbc.M809254200","volume":"284","author":"M Hizume","year":"2009","unstructured":"Hizume, M. et al. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt\u2013Jakob disease infection. J. Biol. Chem. 284(6), 3603\u20133609 (2009).","journal-title":"J. Biol. Chem."},{"issue":"23","key":"12130_CR12","doi-asserted-by":"publisher","first-page":"10926","DOI":"10.1073\/pnas.88.23.10926","volume":"88","author":"LG Goldfarb","year":"1991","unstructured":"Goldfarb, L. G. et al. Transmissible familial Creutzfeldt\u2013Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc. Natl. Acad. Sci. USA 88(23), 10926\u201310930 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Pt 6","key":"12130_CR13","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1093\/brain\/awl076","volume":"129","author":"JD Wadsworth","year":"2006","unstructured":"Wadsworth, J. D. et al. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain 129(Pt 6), 1557\u20131569 (2006).","journal-title":"Brain"},{"issue":"10","key":"12130_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026635","volume":"6","author":"B Li","year":"2011","unstructured":"Li, B., Qing, L., Yan, J. & Kong, Q. Instability of the octarepeat region of the human prion protein gene. PLoS ONE 6(10), e26635 (2011).","journal-title":"PLoS ONE"},{"issue":"8","key":"12130_CR15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1212\/01.wnl.0000267642.41594.9d","volume":"69","author":"S Mead","year":"2007","unstructured":"Mead, S. et al. Inherited prion disease with 5-OPRI: Phenotype modification by repeat length and codon 129. Neurology 69(8), 730\u2013738 (2007).","journal-title":"Neurology"},{"issue":"7","key":"12130_CR16","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","volume":"73","author":"H Bueler","year":"1993","unstructured":"Bueler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73(7), 1339\u20131347 (1993).","journal-title":"Cell"},{"issue":"1","key":"12130_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0896-6273(91)90074-A","volume":"7","author":"D Westaway","year":"1991","unstructured":"Westaway, D. et al. Paradoxical shortening of scrapie incubation times by expression of prion protein transgenes derived from long incubation period mice. Neuron 7(1), 59\u201368 (1991).","journal-title":"Neuron"},{"key":"12130_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1741-7007-4-33","volume":"4","author":"K Juling","year":"2006","unstructured":"Juling, K., Schwarzenbacher, H., Williams, J. L. & Fries, R. A major genetic component of BSE susceptibility. BMC Biol. 4, 33 (2006).","journal-title":"BMC Biol."},{"issue":"4","key":"12130_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1365-2052.2001.0769a.x","volume":"32","author":"D Hills","year":"2001","unstructured":"Hills, D. et al. Complete genomic sequence of the bovine prion gene (PRNP) and polymorphism in its promoter region. Anim. Genet. 32(4), 231\u2013232 (2001).","journal-title":"Anim. Genet."},{"issue":"45","key":"12130_CR20","doi-asserted-by":"publisher","first-page":"37408","DOI":"10.1074\/jbc.M506361200","volume":"280","author":"P Sander","year":"2005","unstructured":"Sander, P. et al. Bovine prion protein gene (PRNP) promoter polymorphisms modulate PRNP expression and may be responsible for differences in bovine spongiform encephalopathy susceptibility. J. Biol. Chem. 280(45), 37408\u201337414 (2005).","journal-title":"J. Biol. Chem."},{"issue":"10","key":"12130_CR21","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1136\/jmg.2006.040931","volume":"43","author":"C Vollmert","year":"2006","unstructured":"Vollmert, C.,Windl, O., Xiang, W., Rosenberger, A., Zerr, I., Wichmann, H-E., Bickeboller, H., Illig, T., Kretzschmar, H. A. Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study. J Med Genet 43(10), e53-e53. https:\/\/doi.org\/10.1136\/jmg.2006.040931 (2006)","journal-title":"J Med Genet"},{"key":"12130_CR22","doi-asserted-by":"publisher","unstructured":"Sanchez-Juan, P., Bishop, M. T., Croes, E. A., Knight, R. S. G., Will, R. G., van Duijn, C. M., Manson, J. C. A polymorphism in the regulatory region of PRNPis associated with increased risk of sporadic Creutzfeldt-Jakob disease. BMC Medical Genetics 12(1). https:\/\/doi.org\/10.1186\/1471-2350-12-73 (2011).","DOI":"10.1186\/1471-2350-12-73"},{"issue":"10","key":"12130_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S1474-4422(20)30273-8","volume":"19","author":"E Jones","year":"2020","unstructured":"Jones, E. et al. Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: A genome-wide association study. Lancet Neurol. 19(10), 840\u2013848 (2020).","journal-title":"Lancet Neurol."},{"issue":"6509","key":"12130_CR24","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"The GTEx Consortium","year":"2020","unstructured":"The GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369(6509), 1318\u20131330 (2020).","journal-title":"Science"},{"issue":"6","key":"12130_CR25","doi-asserted-by":"publisher","first-page":"e156532","DOI":"10.1172\/jci.insight.156532","volume":"7","author":"MA Mortberg","year":"2022","unstructured":"Mortberg, M. A. et al. Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS. JCI Insight 7(6), e156532 (2022).","journal-title":"JCI Insight"},{"issue":"5","key":"12130_CR26","doi-asserted-by":"publisher","first-page":"2004e1-8","DOI":"10.1016\/j.neurobiolaging.2015.01.011","volume":"36","author":"A Lukic","year":"2015","unstructured":"Lukic, A. et al. Rare structural genetic variation in human prion diseases. Neurobiol. Aging 36(5), 2004e1-8 (2015).","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"12130_CR27","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1101\/gr.244939.118","volume":"29","author":"W De Coster","year":"2019","unstructured":"De Coster, W. et al. Structural variants identified by Oxford Nanopore PromethION sequencing of the human genome. Genome Res. 29(7), 1178\u20131187 (2019).","journal-title":"Genome Res."},{"issue":"6","key":"12130_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41588-021-00865-4","volume":"53","author":"D Beyter","year":"2021","unstructured":"Beyter, D. et al. Long-read sequencing of 3,622 Icelanders provides insight into the role of structural variants in human diseases and other traits. Nat. Genet. 53(6), 779\u2013786 (2021).","journal-title":"Nat. Genet."},{"issue":"7","key":"12130_CR29","doi-asserted-by":"publisher","first-page":"E1551","DOI":"10.1002\/humu.21281","volume":"31","author":"JA Beck","year":"2010","unstructured":"Beck, J. A. et al. PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum. Mutat. 31(7), E1551\u2013E1563 (2010).","journal-title":"Hum. Mutat."},{"issue":"1\u20132","key":"12130_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0378-1119(01)00424-3","volume":"268","author":"SP Mahal","year":"2001","unstructured":"Mahal, S. P., Asante, E. A., Antoniou, M. & Collinge, J. Isolation and functional characterisation of the promoter region of the human prion protein gene. Gene 268(1\u20132), 105\u2013114 (2001).","journal-title":"Gene"},{"issue":"13","key":"12130_CR31","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1093\/bioinformatics\/bty841","volume":"35","author":"A Payne","year":"2019","unstructured":"Payne, A., Holmes, N., Rakyan, V. & Loose, M. BulkVis: A graphical viewer for Oxford nanopore bulk FAST5 files. Bioinformatics 35(13), 2193\u20132198 (2019).","journal-title":"Bioinformatics"},{"issue":"12","key":"12130_CR32","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/hmg\/ddh134","volume":"13","author":"JA Beck","year":"2004","unstructured":"Beck, J. A. et al. Somatic and germline mosaicism in sporadic early-onset Alzheimer\u2019s disease. Hum. Mol. Genet. 13(12), 1219\u20131224 (2004).","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"12130_CR33","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3390\/cells9061480","volume":"9","author":"YC Kim","year":"2020","unstructured":"Kim, Y. C., Won, S. Y. & Jeong, B. H. Identification of prion disease-related somatic mutations in the prion protein gene (PRNP) in cancer patients. Cells 9(6), 1480 (2020).","journal-title":"Cells"},{"issue":"3","key":"12130_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/nan.12465","volume":"44","author":"M Leija-Salazar","year":"2018","unstructured":"Leija-Salazar, M., Piette, C. & Proukakis, C. Review: somatic mutations in neurodegeneration. Neuropathol. Appl. Neurobiol. 44(3), 267\u2013285 (2018).","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"12130_CR35","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1038\/s41467-019-11000-7","volume":"10","author":"JS Park","year":"2019","unstructured":"Park, J. S. et al. Brain somatic mutations observed in Alzheimer\u2019s disease associated with aging and dysregulation of tau phosphorylation. Nat. Commun. 10(1), 3090 (2019).","journal-title":"Nat. Commun."},{"key":"12130_CR36","doi-asserted-by":"publisher","first-page":"631","DOI":"10.12688\/f1000research.11547.1","volume":"6","author":"R White","year":"2017","unstructured":"White, R. et al. Investigation of chimeric reads using the MinION. F1000Research 6, 631 (2017).","journal-title":"F1000Research"},{"key":"12130_CR37","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.3389\/fmicb.2018.02225","volume":"9","author":"Y Xu","year":"2018","unstructured":"Xu, Y. et al. Detection of viral pathogens with multiplex nanopore MinION sequencing: Be careful with cross-talk. Front. Microbiol. 9, 2225 (2018).","journal-title":"Front. Microbiol."},{"issue":"10","key":"12130_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257521","volume":"16","author":"C Delahaye","year":"2021","unstructured":"Delahaye, C. & Nicolas, J. Sequencing DNA with nanopores: Troubles and biases. PLoS ONE 16(10), e0257521 (2021).","journal-title":"PLoS ONE"},{"issue":"4","key":"12130_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41587-020-0407-5","volume":"38","author":"T Gilpatrick","year":"2020","unstructured":"Gilpatrick, T. et al. Targeted nanopore sequencing with Cas9-guided adapter ligation. Nat. Biotechnol. 38(4), 433\u2013438 (2020).","journal-title":"Nat. Biotechnol."},{"key":"12130_CR40","doi-asserted-by":"crossref","unstructured":"Stevanovski, I., et al. Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing. medRxiv (2021).","DOI":"10.1101\/2021.09.27.21263187"},{"issue":"1","key":"12130_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336896.2019.1702446","volume":"14","author":"ME Guere","year":"2020","unstructured":"Guere, M. E. et al. Chronic wasting disease associated with prion protein gene (PRNP) variation in Norwegian wild reindeer (Rangifer tarandus). Prion 14(1), 1\u201310 (2020).","journal-title":"Prion"},{"issue":"49","key":"12130_CR42","doi-asserted-by":"publisher","first-page":"31417","DOI":"10.1073\/pnas.2013237117","volume":"117","author":"R Nonno","year":"2020","unstructured":"Nonno, R. et al. Studies in bank voles reveal strain differences between chronic wasting disease prions from Norway and North America. Proc. Natl. Acad. Sci. USA 117(49), 31417\u201331426 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"12130_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrm2854","volume":"11","author":"A Lopez Castel","year":"2010","unstructured":"Lopez Castel, A., Cleary, J. D. & Pearson, C. E. Repeat instability as the basis for human diseases and as a potential target for therapy. Nat. Rev. Mol. Cell Biol. 11(3), 165\u2013170 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"12130_CR44","unstructured":"Mad-Cow.org. Origin of extra prion repeat units. Available online (1999)."},{"issue":"3","key":"12130_CR45","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1101\/gr.198602","volume":"12","author":"D Metzgar","year":"2002","unstructured":"Metzgar, D., Liu, L., Hansen, C., Dybvig, K. & Wills, C. Domain-level differences in microsatellite distribution and content result from different relative rates of insertion and deletion mutations. Genome Res. 12(3), 408\u2013413 (2002).","journal-title":"Genome Res."},{"issue":"16","key":"12130_CR46","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/hmg\/ddh186","volume":"13","author":"M Gomes-Pereira","year":"2004","unstructured":"Gomes-Pereira, M., Fortune, M. T., Ingram, L., McAbney, J. P. & Monckton, D. G. Pms2 is a genetic enhancer of trinucleotide CAG.CTG repeat somatic mosaicism: Implications for the mechanism of triplet repeat expansion. Hum. Mol. Genet. 13(16), 1815\u20131825 (2004).","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"12130_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3233\/JHD-200429","volume":"10","author":"DG Monckton","year":"2021","unstructured":"Monckton, D. G. The contribution of somatic expansion of the CAG repeat to symptomatic development in Huntington\u2019s disease: A historical perspective. J. Huntington\u2019s Dis. 10(1), 7\u201333 (2021).","journal-title":"J. Huntington\u2019s Dis."},{"issue":"5910","key":"12130_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1126\/science.1162986","volume":"323","author":"J Eid","year":"2009","unstructured":"Eid, J. et al. Real-time DNA sequencing from single polymerase molecules. Science 323(5910), 133\u2013138 (2009).","journal-title":"Science"},{"issue":"6","key":"12130_CR49","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00401-020-02224-9","volume":"140","author":"LC Dabin","year":"2020","unstructured":"Dabin, L. C. et al. Altered DNA methylation profiles in blood from patients with sporadic Creutzfeldt\u2013Jakob disease. Acta Neuropathol. 140(6), 863\u2013879 (2020).","journal-title":"Acta Neuropathol."},{"issue":"2","key":"12130_CR50","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1212\/WNL.57.2.354","volume":"57","author":"JA Beck","year":"2001","unstructured":"Beck, J. A. et al. Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia. Neurology 57(2), 354\u2013356 (2001).","journal-title":"Neurology"},{"issue":"5","key":"12130_CR51","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1101\/gr.215087.116","volume":"27","author":"S Koren","year":"2017","unstructured":"Koren, S. et al. Canu: Scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation. Genome Res. 27(5), 722\u2013736 (2017).","journal-title":"Genome Res."},{"key":"12130_CR52","unstructured":"Simpson, J. Nanopolish. https:\/\/github.com\/jts\/nanopolish (2020)."},{"issue":"18","key":"12130_CR53","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li, H. Minimap2: Pairwise alignment for nucleotide sequences. Bioinformatics 34(18), 3094\u20133100 (2018).","journal-title":"Bioinformatics"},{"issue":"16","key":"12130_CR54","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25(16), 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"12130_CR55","unstructured":"GATKTeam. StrandOddsRatio (2019)."},{"issue":"6","key":"12130_CR56","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1089\/cmb.2014.0157","volume":"22","author":"M Patterson","year":"2015","unstructured":"Patterson, M. et al. WhatsHap: Weighted haplotype assembly for future-generation sequencing reads. J. Comput. Biol. 22(6), 498\u2013509 (2015).","journal-title":"J. Comput. Biol."},{"issue":"6","key":"12130_CR57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41592-018-0001-7","volume":"15","author":"FJ Sedlazeck","year":"2018","unstructured":"Sedlazeck, F. J. et al. Accurate detection of complex structural variations using single-molecule sequencing. Nat. Methods 15(6), 461\u2013468 (2018).","journal-title":"Nat. Methods"},{"issue":"22","key":"12130_CR58","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","volume":"22","author":"JD Thompson","year":"1994","unstructured":"Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22(22), 4673\u20134680 (1994).","journal-title":"Nucleic Acids Res."},{"key":"12130_CR59","doi-asserted-by":"crossref","unstructured":"Bodenhofer, U., Bonatesta, E., Horej\u0161-Kainrath, C. & Hochreiter, S. msa: an R package for multiple sequence alignment. Bioinformatics 31(24), 3997\u20133999 (2015).","DOI":"10.1093\/bioinformatics\/btv494"},{"issue":"1","key":"12130_CR60","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13104-019-4137-z","volume":"12","author":"A Piovesan","year":"2019","unstructured":"Piovesan, A. et al. On the length, weight and GC content of the human genome. BMC Res. Notes 12(1), 106 (2019).","journal-title":"BMC Res. Notes"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12130-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12130-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12130-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T21:54:11Z","timestamp":1669326851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12130-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12130"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12130-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.06.22271294","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. Collinge is a director and shareholder of D-Gen Limited (London), an academic spinout company working in the field of prion disease diagnosis, decontamination and therapeutics. Fran\u00e7ois Kroll owns stocks in Oxford Nanopore Technologies and Pacific Biosciences. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8284"}}